“Attention Shareholders: Important Reminder from Levi & Korsinsky Regarding Lead Plaintiff Deadline”
Regeneron Pharmaceuticals, Inc.: Understanding Securities Laws Introduction Recently, if you have experienced a loss on your investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), you may be eligible for a potential recovery under the federal securities laws. It is crucial to be informed about your rights and options in such situations. To learn more about the steps…